Labiotech.eu

News and Trends 14 Jun 2017

Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer

The RAIDs consortium made its closing event last week. After 4.5 years of studies, it has managed to change our appreciation of HPV cervical cancer towards building intelligent targeted therapy designs. Every year in Europe, 16,000 women die from cervical cancer and another 34,000 are newly diagnosed, which makes it the second most frequent form […]

June 14, 2017 - 5 minutesmins - By Timothé Cynober

News and Trends 14 Jun 2017

French Hepatitis Cure is on Track with Positive Phase I Results

Enyo Pharma has announced that its lead candidate EYP001, indicated for the treatment of hepatitis B, successfully cleared a Phase Ia trial. Enyo Pharma is one of the hottest biotechs in Lyon that is developing new treatments against viruses, including hepatitis B or severe influenza infections. Its key asset, EYP001, is a farnesoid X receptor (FXR) agonist indicated […]

June 14, 2017 - 3 minutesmins - By Melanie De Almeida

Centogene Rare Disease Diagnostics Series A

News and Trends 13 Jun 2017

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases

Centogene has raised €25M in a Series A round to support the global expansion of its genome analysis platform, which is specialized in rare diseases. The German biotech Centogene is pioneering the development of genetic diagnostic tests to address the challenges of personalized medicine in order to match therapies more effectively to patients. Founded in 2005, the […]

June 13, 2017 - 2 minutesmins - By Melanie De Almeida

In Depth 13 Jun 2017

Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?

In the US, the first CRISPR-edited crops were able to bypass GMO regulations, but Europe’s plant scientists are still awaiting the final go ahead. In April 2016, the US Department of Agriculture (USDA) gave the green light to the first CRISPR-edited crops, a mushroom that has been engineered to resist browning and a waxy corn from […]

June 13, 2017 - 6 minutesmins - By Melanie De Almeida

News and Trends 12 Jun 2017

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

BioNTech has reported a new technology that could overcome some of the most challenging issues of antibody production by encoding them into mRNA drugs. BioNTech, one of the most advanced companies in the mRNA therapeutics field, has reported preclinical data for a new class of mRNA drugs that instruct the body to create its own […]

June 12, 2017 - 3 minutesmins - By Clara Rodríguez Fernández

News and Trends 12 Jun 2017

Norwegian Biotech Hits €21M in Private Placement for its Immunotherapies

Targovax has raised €21M (NOK200M) in a private placement, which the biotech will use to fund data read-outs from clinical trials and CMC development. Targovax, based in Oslo, is developing a number of immunotherapies for treatment-resistant tumors. The biotech’s pipeline is based on its two platforms, ONCOS, an oncolytic virus, which is being developed to treat melanoma, […]

June 12, 2017 - 2 minutesmins - By Melanie De Almeida

p450 enzymes bioactive compounds fermentation

More News! 12 Jun 2017

Bacteria copy a Powerhouse in Plants to Produce Useful Molecules

Danish researchers managed to sneak the genetic information needed to make P450 enzymes into E. coli. These enzymes are used by plants to make bioactive compounds and can be used for new industrial production processes of several drugs. Researchers from the Novo Nordisk Foundation Center for Biosustainability have been focusing on developing an alternative way to produce a plant enzyme, the cytochrome P450, for industrial […]

June 12, 2017 - 2 minutesmins - By Denise Neves Gameiro

News and Trends 12 Jun 2017

German Biotech Unveils Positive Phase II Results for Alzheimer’s

Probiodrug has disclosed encouraging results of its latest Phase IIa trial to assess its lead candidate PQ912 in patients with early Alzheimer’s Disease. The German biotech Probiodrug is pioneering new approaches to eliminate pyroglutamate (pGlu)-Abeta, a peptide that has been linked to the formation of toxic oligomers involved in Alzheimer’s disease. Now, the biotech came out […]

June 12, 2017 - 3 minutesmins - By Melanie De Almeida

Interview 12 Jun 2017

This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK

Paolo Paoletti might have been forced to reconsider his career as a professor in medicine, but academia’s loss was biopharma’s gain! Before becoming CEO of one of London’s most exciting biotechs, GammaDelta Therapeutics, Paolo Paoletti had a long run through the corporate ranks of pharma. He was coaxed out of academic medicine to join Eli […]

June 12, 2017 - 9 minutesmins - By Evelyn Warner

More News! 10 Jun 2017

This Turkish Bioartist Creates Beautiful Maps out of Fungi

Selin Balci uses fungi as a medium to create living maps that explore the complexity of microscopic life and its similarity with human behavior. Selin Balci got a degree in microbiology from Istanbul University and worked in research for 5 years before turning to art. Her work combines her experience culturing fungi and mold with creative experimentation to obtain colorful […]

June 10, 2017 - 2 minutesmins - By Clara Rodríguez Fernández

Interview 8 Jun 2017

Cambridge Antibody Technology: The History of the UK’s Best Biotech

CAT was the first of Greg Winter’s three antibody-related companies and one of the UK’s biggest success stories in biotech. How did he pull it off? Sir Greg Winter is one of the biggest names in European biotech. As a Professor of Biochemistry at Cambridge University, he developed phage display technology that became the foundation […]

June 8, 2017 - 7 minutesmins - By Evelyn Warner

News and Trends 7 Jun 2017

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

Here are the most innovative therapies presented by European biotechs fighting cancer during the ASCO 2017 meeting in Chicago. European biotech was in the spotlight during this year’s edition of the American Society of Clinical Oncology (ASCO) meeting, with impressive results from some of the most novel approaches under development to fight multiple forms of cancer. From a […]

June 7, 2017 - 5 minutesmins - By Clara Rodríguez Fernández

Knowledge hub

Categories

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

Approaches

Therapeutic areas

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

R&D

BD

World biotech leaders

Connect with decision-makers and researchers worldwide for collaborative opportunities

Company

Join Us

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Results are in for Europe’s First Biobanking Study on HPV Cervical Cancer

French Hepatitis Cure is on Track with Positive Phase I Results

German Biotech Raises €25M to Fuel Diagnostics of Rare Diseases

Will Gene Editing Bypass the GMO Struggle or Worsen Public Distrust?

BioNTech Publishes First Data on mRNA-Encoded Cancer Antibodies

Norwegian Biotech Hits €21M in Private Placement for its Immunotherapies

Bacteria copy a Powerhouse in Plants to Produce Useful Molecules

German Biotech Unveils Positive Phase II Results for Alzheimer’s

This Italian Academic-turned-CEO also Launched 7 Cancer Drugs at GSK

This Turkish Bioartist Creates Beautiful Maps out of Fungi

Cambridge Antibody Technology: The History of the UK’s Best Biotech

What Cancer Therapies did European Biotechs Showcase at ASCO 2017?

Subscribe to our newsletter to get the latest biotech news!

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Illuminating biotech in the City of Light: Inside Paris’s thriving ecosystem

ASCO 2025: key highlights in cancer therapeutics

New report: Artificial intelligence and the future of antibody discovery

Stem cell therapy: a potential cure for hearing loss?

Connect with decision-makers and researchers worldwide for collaborative opportunities

Subscribe to our newsletter

Advertise with us

Subscribe to our newsletter

Get the latest biotech news directly to your inbox!

Newsletter Signup - Footer

Subscribe to our newsletter to get the latest biotech news!